Your session is about to expire
← Back to Search
Modified mRNA Vaccines for Infectious Diseases
Study Summary
This trial is testing how safe and effective a potential vaccine is.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2022 Phase 3 trial • 30415 Patients • NCT04470427Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- I am between 18 and 75 years old and in good health, or between 18 and under 50 for certain study arms.I had flu, RSV, or COVID-19 confirmed by a test recently.I have not taken drugs that weaken my immune system for more than 14 days in the last 6 months.I haven't been in a clinical study in the last 28 days and won't join another for 12 months after my last study vaccine.I have been vaccinated for flu, RSV, or CMV within the last 6 months, or haven't completed my COVID-19 vaccination series.Your body mass index (BMI) should be between 18 and 35.I plan to get a vaccine within 28 days of any study injection.I have been vaccinated for COVID-19 within the last 4 months or haven't completed the vaccine series.I have been in close contact with someone who had COVID-19, RSV, or the flu in the last 2 weeks.I am between 18 and 75 years old and in good health.I am between 18 and 49 years old and in good health.You had a bad allergic reaction to any part of the FLUAD vaccine or to any flu shot in the past.Your body mass index (BMI) is between 18 and 35.
- Group 1: Part 1: mRNA-1345
- Group 2: Part 1: mRNA-1647 2-Dose
- Group 3: Part 1: mRNA-1647 3-Dose
- Group 4: Part 2: mRNA-1273
- Group 5: Part 2: mRNA-1010
- Group 6: Part 2: FLUAD®
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How widely is this medical research being conducted across the city?
"Multiple trial sites are accepting enrolments, including Meridian Clinical Research in Lincoln, DM Clinical Research- Texas Center for Drug Development in Sioux City and Tekton Research Inc. located in Houston. Several other locations are also participating."
Are participants aged 45 and over able to join this research project?
"Individuals that meet the age requirements of 18 years or more and 75 years or less are welcome to participate in this medical trial."
Is it possible for me to participate in this research endeavor?
"To be eligible for this clinical trial, individuals must have been diagnosed with covid-19 and fall between 18 - 75 years old. 300 people are expected to join the study."
Are there still openings in this investigation for participants?
"Affirmative, the information hosted on clinicaltrials.gov confirms that recruiting is underway for this medical trial which originally went live on May 24th 2022. The study has recently been updated and now requires 300 patients to be enrolled from 8 distinct sites."
How many participants are actively participating in this experiment?
"To ensure a successful trial, 300 individuals must partake in the study and meet certain eligibility criteria. Multiple medical sites such as Meridian Clinical Research (Lincoln, Nebraska) or DM Clinical Research- Texas Center for Drug Development (Sioux City, Iowa) are available to recruit patients from."
Has the FDA accepted mRNA-1273 for clinical use?
"Limited data backing the safety and efficacy of mRNA-1273 resulted in it receiving a score of 1."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger